论文部分内容阅读
英国MHRA忠告:血管紧张素转换酶抑制药(ACEI)及血管紧张素Ⅱ受体拮抗药(ARB)是适用于各种高血压病的治疗药,但它不适用于任何阶段的孕妇。另外,对将要计划怀孕的妇女也不能应用。MHRA的忠告是基于一项同期组群超声研究的结果而提出的。它注意到ACEI可导致发生先天性异常新生儿危险的增加,其实在使用血管紧张素Ⅱ受
British MHRA Advice: Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor antagonists (ARBs) are therapeutic agents for a variety of hypertensive disorders, but they are not suitable for pregnant women at any stage. In addition, women who plan to become pregnant can not be used. MHRA’s advice is based on the results of a cohort ultrasound study. It notes that ACEI can lead to an increased risk of congenital abnormalities in newborns, in fact, the use of angiotensin Ⅱ